气道疾病的精准医学:迈向临床实践
2017年欧洲呼吸学会研究研讨会在巴塞罗那召开,讨论如何将精准医学应用于哮喘和慢阻肺等慢性气道疾病。文章总结该研讨会报告与讨论,涉及疾病新分类学、暴露组、基因、内型、表型、生物标志物和可治疗特征的作用,以及临床实践中的部署和未来研究方向。
要点
- 哮喘与慢阻肺是复杂异质性疾病,常重叠,需个体化评估与治疗。
- 精准医学应用涉及暴露组、基因、内型、表型、生物标志物和可治疗特征。
- 需在初级和专科护理中部署气道精准医学,并推进相关研究。
核心结论
- 哮喘和慢阻肺是复杂异质且常重叠的疾病,需要个体化评估和治疗。
- 精准医学在气道疾病中的临床应用需考虑新分类学及暴露组、基因、内型等多因素。
研究设计与样本
- 本文总结2017年2月21日在巴塞罗那举行的欧洲呼吸学会研究研讨会的报告与讨论。
主要发现
- 研讨会讨论了人类疾病新分类学的需求及暴露组、基因、内型、表型、生物标志物和可治疗特征的作用。
- 研讨会涉及气道精准医学在初级和专科护理中部署的未解关键问题及所需研究方向。
临床怎么用
- 在初级和专科护理中部署气道精准医学,对哮喘和慢阻肺进行个体化评估与治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
On February 21, 2017, a European Respiratory Society research seminar held in Barcelona discussed how to best apply precision medicine to chronic airway diseases such as asthma and chronic obstructive pulmonary disease. It is now clear that both are complex and heterogeneous diseases, that often overlap and that both require individualised assessment and treatment. This paper summarises the presentations and discussions that took place during the seminar. Specifically, we discussed the need for a new taxonomy of human diseases, the role of different players in this scenario (exposome, genes, endotypes, phenotypes, biomarkers and treatable traits) and a number of unanswered key questions in the field. We also addressed how to deploy airway precision medicine in clinical practice today, both in primary and specialised care. Finally, we debated the type of research needed to move the field forward.
引用
- Agustí A, Bafadhel M, Beasley R, et al. Precision medicine in airway diseases: moving to clinical practice. Eur Respir J. 2017. PMID: 29051276. doi:10.1183/13993003.01655-2017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。